Epidemiology Practice Questions

Q: Regarding Randomized Controlled Trials, all statements are true EXCEPT:

Dropouts are excluded from the study.. In Randomized Controlled Trials (RCTs), the goal is to maintain the integrity of the randomization process and ensure the results are applicable to real-world clinical practice. **Explanation of the Correct Answer (Option D):** The statement "Dropouts are excluded from the study" is **false** because of the **Intention-to-Treat (ITT) Analysis** principle. In a gold-standard RCT, all participants who were randomized must be analyzed in the groups to which they were originally assigned, regardless of whether they dropped out, were non-compliant, or switched treatments. Excluding dropouts leads to **Selection Bias** and overestimates the efficacy of the intervention. **Analysis of Incorrect Options:** * **Option A:** Randomization ensures that both known and unknown confounding factors are distributed equally between groups, making **baseline characteristics comparable**. * **Option B:** Blinding (Masking) is specifically designed to **eliminate observation/ascertainment bias**. Double-blinding ensures neither the patient nor the investigator knows the treatment allocation. * **Option C:** Sample size is a critical prerequisite for an RCT. It depends on the study design, expected effect size, statistical power ($1-\beta$), and significance level ($\alpha$). **High-Yield Clinical Pearls for NEET-PG:** * **Randomization** is the "Heart of an RCT"; it eliminates **Selection Bias**. * **Blinding** eliminates **Measurement/Information Bias**. * **Intention-to-Treat (ITT) Analysis** preserves the benefits of randomization and maintains the statistical power of the study. * **Per-Protocol Analysis** (analyzing only those who completed the study) is used to determine the "efficacy" under ideal conditions but is prone to bias.

Q: What is the incubation period of Hepatitis B?

50-160 days. **Explanation:** The incubation period of a disease is the interval between the entry of the pathogen and the appearance of the first clinical sign or symptom. For **Hepatitis B Virus (HBV)**, the incubation period is characteristically long and variable, typically ranging from **30 to 180 days**, with an average of **50–160 days**. * **Why Option B is Correct:** According to standard epidemiological textbooks (like Park’s PSM), Hepatitis B is known as "long-incubation hepatitis." The 50-160 day window reflects the slow replication cycle of the DNA virus and the time required for the host's immune response to trigger clinical symptoms. * **Why Option A is Incorrect:** 15–50 days (average 28-30 days) is the incubation period for **Hepatitis A and Hepatitis E**. These are transmitted via the fecal-oral route and have a much shorter clinical onset. * **Why Option C & D are Incorrect:** 10 days is too short for any viral hepatitis. While 100 days falls within the range of Hepatitis B, it is a single point in time rather than the established epidemiological range (50-160 days) used for classification. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis B:** DNA virus (Hepadnaviridae); incubation 50–160 days. * **Hepatitis C:** Incubation period is **30–120 days** (Average 6-7 weeks). * **Rule of Thumb:** Hepatitis A and E (Fecal-oral) are "Short Incubation," while B, C, and D (Parenteral) are "Long Incubation." * **HBsAg:** The first serological marker to appear in blood after infection (even before symptoms).

Q: A country with a zero population growth rate is in which stage of the demographic cycle?

Fourth. **Explanation:** The **Demographic Cycle** describes the historical shift in birth and death rates as a country develops. The correct answer is **Stage 4 (Low Stationary)** because this is the phase where the birth rate declines to match the already low death rate, resulting in a **Zero Population Growth (ZPG)** rate. **Breakdown of Stages:** * **Stage 1 (High Stationary):** Characterized by high birth and high death rates. The population remains stable but at a low level. * **Stage 2 (Early Expanding):** Death rates begin to fall due to improved healthcare and sanitation, while birth rates remain high. This leads to the "population explosion." * **Stage 3 (Late Expanding):** Death rates continue to fall, and birth rates finally begin to decline. The population still grows, but at a slower pace. * **Stage 4 (Low Stationary):** Both birth and death rates are low and equal. This is where **Zero Population Growth** occurs (e.g., many European countries). * **Stage 5 (Declining):** Birth rates fall below death rates, leading to a negative growth rate and a shrinking population (e.g., Germany, Japan). **High-Yield NEET-PG Pearls:** * **India's Status:** Currently, India is in **Late Stage 3** of the demographic cycle. * **Net Reproduction Rate (NRR):** For a country to achieve ZPG, the NRR must be **1**. * **Total Fertility Rate (TFR):** The replacement level fertility required for ZPG is approximately **2.1**. * **Key Indicator:** The transition from Stage 2 to Stage 3 is primarily driven by a decline in the birth rate.

Q: A person wants to study the association between a disease and fat consumption. Data for the number of people affected with the disease was obtained from the government, and details of fat consumption were obtained from the food industry. What type of study design is this?

Ecological study. ### Explanation **Why Ecological Study is Correct:** The hallmark of an **Ecological Study** (also known as a correlational study) is that the **unit of observation is a population or a group**, rather than an individual. In this scenario, the researcher is using aggregate data: disease prevalence from government records and fat consumption statistics from the food industry. Since the data describes entire populations (e.g., countries or states) and does not link specific fat intake to specific individuals, it is an ecological study. These studies are often used to generate hypotheses and are prone to "Ecological Fallacy" (assuming an association observed at the group level applies to every individual). **Why the Other Options are Incorrect:** * **B. Cross-sectional study:** This study uses the **individual** as the unit of observation. It measures exposure and outcome simultaneously in individuals at a single point in time (a "snapshot"). * **C. Observational study:** While an ecological study *is* a type of observational study, this option is too broad. In NEET-PG, you must always choose the **most specific** correct answer. * **D. Experimental study:** These involve an intervention (like a drug or diet) controlled by the researcher (e.g., RCTs). Here, the researcher is merely observing existing data. **High-Yield Clinical Pearls for NEET-PG:** * **Unit of Study:** * Ecological: Populations/Groups. * Cross-sectional/Case-control/Cohort: Individuals. * **Ecological Fallacy:** The major limitation where an error is made by inferring individual-level associations from group-level data. * **Use Case:** Ecological studies are the quickest and cheapest way to look for geographical or temporal trends in disease.

Q: All of the following are true regarding tetanus except:

It is transmitted from person to person. **Explanation:** The correct answer is **A (It is transmitted from person to person)** because Tetanus is a non-communicable disease. Unlike many infectious diseases, it is not transmitted from one person to another. Infection occurs through the contamination of wounds with *Clostridium tetani* spores. **Analysis of Options:** * **Option A (Correct):** Tetanus is unique because it lacks person-to-person transmission. It is an environmental infection rather than a contagious one. * **Option B:** Herd immunity is irrelevant in Tetanus because the disease is not spread through human contact. Protection is strictly individual and depends entirely on active immunization (Tetanus Toxoid). * **Option C:** The primary reservoir for *C. tetani* is the soil and the intestinal tracts of animals (horses, cattle) and humans, where the organism exists in a commensal state. Spores are highly resistant and can persist in the environment for years. * **Option D:** The typical incubation period is 3 to 21 days, with an average of **6–10 days**. Generally, a shorter incubation period is associated with a poorer prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Neonatal Tetanus:** Known as the "8th-day disease," usually caused by unsterile cord cutting. * **Elimination Goal:** Maternal and Neonatal Tetanus (MNT) elimination is defined as <1 case per 1,000 live births per district per year. India achieved this in 2015. * **Pathogenesis:** Caused by **Tetanospasmin**, a potent neurotoxin that blocks the release of inhibitory neurotransmitters (GABA and Glycine), leading to spastic paralysis. * **Clinical Signs:** Trismus (lockjaw), Risus sardonicus (grimace), and Opisthotonus (arch-shaped back).

Q: Which vaccine is most effective in achieving herd immunity?

Oral Polio Vaccine (OPV). **Explanation:** The correct answer is **Oral Polio Vaccine (OPV)**. **Why OPV is the most effective:** Herd immunity occurs when a significant portion of a population becomes immune to an infectious disease, reducing the likelihood of transmission. OPV is uniquely effective at achieving this through two mechanisms: 1. **Intestinal Immunity:** OPV (a live-attenuated vaccine) induces strong local mucosal immunity (IgA) in the gut. This prevents the wild poliovirus from replicating in the intestines, thereby blocking fecal-oral transmission. 2. **Secondary Spread (Contact Immunization):** The attenuated vaccine virus is excreted in the stools of the vaccinated child. This virus can then spread to unvaccinated contacts in areas with poor sanitation, effectively "vaccinating" them indirectly. This phenomenon is a hallmark of OPV and is the primary reason it was chosen for global polio eradication. **Why other options are incorrect:** * **Typhoid and Cholera vaccines:** While these vaccines provide individual protection, they do not induce a high enough level of herd immunity to interrupt community transmission effectively. Their efficacy is relatively lower, and they do not possess the "secondary spread" characteristic of live-attenuated oral vaccines like OPV. **High-Yield Clinical Pearls for NEET-PG:** * **Herd Immunity Threshold:** For Polio, it is estimated at **80-85%**. For Measles (the most contagious), it is **94-95%**. * **IPV vs. OPV:** Unlike OPV, the Inactivated Polio Vaccine (IPV) provides systemic immunity (IgG) but **minimal intestinal immunity**. Therefore, IPV protects the individual from paralysis but does not stop the spread of the wild virus in the community as effectively as OPV. * **Prerequisite for Herd Immunity:** The disease agent must be restricted to a single host species (humans) and have a direct transmission mechanism. Herd immunity does **not** apply to Tetanus, as the reservoir is soil, not humans.

Q: Herd immunity is not useful in which of the following diseases?

Tetanus. **Explanation** The correct answer is **Tetanus**. **1. Why Tetanus is the correct answer:** Herd immunity (community immunity) occurs when a large portion of a population becomes immune to an infectious disease, thereby reducing the likelihood of person-to-person transmission. For herd immunity to be effective, the disease must be **communicable** (spread from one individual to another). Tetanus is caused by *Clostridium tetani* spores found in the soil. It is **non-communicable**; an infected person cannot transmit the disease to others. Therefore, vaccinating 99% of a population does not protect the remaining 1% from environmental exposure. Protection against tetanus is strictly individual. **2. Why the other options are incorrect:** * **Diphtheria, Polio, and Measles** are all highly communicable diseases spread via respiratory droplets or the feco-oral route. * In these cases, when a critical threshold of the population is immune (via vaccination or natural infection), the chain of transmission is broken, protecting unvaccinated or immunocompromised individuals in the community. **3. High-Yield Clinical Pearls for NEET-PG:** * **Herd Immunity Threshold:** The proportion of immune individuals required to stop transmission. It is calculated as $1 - (1/R_0)$. * **Measles:** Requires the highest herd immunity threshold (approx. 94–95%) due to its high basic reproduction number ($R_0$). * **Prerequisites for Herd Immunity:** 1. The agent must be restricted to a single host species (humans). 2. Transmission must be direct (person-to-person). 3. Infection must induce solid, long-lasting immunity. * **Tetanus** is the classic exception used in exams to test the understanding that herd immunity does not apply to environmental/non-communicable pathogens.

Question 1

Regarding Randomized Controlled Trials, all statements are true EXCEPT:

Accepted Answer

Dropouts are excluded from the study.

Answer

Baseline characteristics are comparable.

Answer

Bias can be eliminated by double blinding.

Answer

Sample size depends on the type of study.

Question 2

What is the incubation period of Hepatitis B?

Accepted Answer

50-160 days

Answer

15-50 days

Answer

10 days

Answer

100 days

Question 3

A country with a zero population growth rate is in which stage of the demographic cycle?

Accepted Answer

Fourth

Answer

First

Answer

Second

Answer

Third

Question 4

A person wants to study the association between a disease and fat consumption. Data for the number of people affected with the disease was obtained from the government, and details of fat consumption were obtained from the food industry. What type of study design is this?

Accepted Answer

Ecological study

Answer

Cross-sectional study

Answer

Observational study

Answer

Experimental study

Question 5

All of the following are true regarding tetanus except:

Accepted Answer

It is transmitted from person to person

Answer

Herd immunity is not of much value

Answer

The main reservoir is soil and intestine of animals and humans

Answer

Incubation period is 6-10 days

Question 6

What is the most important epidemiological tool used for assessing disability in children?

Accepted Answer

Wing's Handicaps, Behaviour and Skills (HBS) Schedule

Answer

Activities of Daily Living (ADL) scale

Answer

Binet and Simon IQ tests

Answer

Physical Quality of Life Index (PQL 1)

Question 7

Dose-response relationship is a measure of:

Accepted Answer

Strength of association

Answer

Consistency of association

Answer

Consistency of association

Answer

Specificity of association

Question 8

Which vaccine is most effective in achieving herd immunity?

Accepted Answer

Oral Polio Vaccine (OPV)

Answer

Typhoid vaccine

Answer

Cholera vaccine

Answer

None of the above

Question 9

What is the base population size for a registered cancer study?

Accepted Answer

1-2 million

Answer

1-3 million

Answer

2-5 million

Answer

3-7 million

Question 10

Herd immunity is not useful in which of the following diseases?

Accepted Answer

Tetanus

Answer

Diphtheria

Answer

Polio

Answer

Measles

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?